Albert Deisseroth

7.8k total citations · 1 hit paper
139 papers, 5.7k citations indexed

About

Albert Deisseroth is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Albert Deisseroth has authored 139 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 50 papers in Oncology and 41 papers in Hematology. Recurrent topics in Albert Deisseroth's work include Virus-based gene therapy research (32 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Albert Deisseroth is often cited by papers focused on Virus-based gene therapy research (32 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Albert Deisseroth collaborates with scholars based in United States, United Kingdom and Türkiye. Albert Deisseroth's co-authors include Wei Zhang, Arthur W. Nienhuis, Philip A. Pizzo, Richard Pazdur, Ann T. Farrell, Wei Zhang, Daniel G. Wright, Laurie B. Owen‐Schaub, Weiwei Zhang and Robert Radinsky and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Albert Deisseroth

136 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression

1995 615 citations Laurie B. Owen‐Schaub, Wei Zhang et al. Molecular and Cellular Biology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Albert Deisseroth	2.6k	2.4k	1.1k	1.0k	937	139	5.7k
Fabien Calvo	3.3k 1.2×	2.3k 1.0×	601 0.5×	842 0.8×	719 0.8×	160	6.7k
HP Koeffler	3.1k 1.2×	1.8k 0.7×	2.0k 1.9×	1.6k 1.6×	825 0.9×	90	6.5k
Albert F. LoBuglio	3.6k 1.4×	2.9k 1.2×	892 0.8×	3.0k 3.0×	867 0.9×	189	9.5k
Martin Haas	2.5k 0.9×	2.1k 0.9×	333 0.3×	904 0.9×	902 1.0×	160	6.3k
Salvatore Venuta	2.2k 0.8×	1.6k 0.6×	656 0.6×	1.4k 1.4×	606 0.6×	137	5.1k
George Morstyn	1.1k 0.4×	2.6k 1.1×	1.5k 1.3×	1.1k 1.0×	1.2k 1.3×	110	5.7k
E. Anders Kolb	3.1k 1.2×	1.8k 0.7×	1.2k 1.1×	401 0.4×	583 0.6×	283	6.2k
Sanford A. Stass	3.7k 1.4×	1.8k 0.8×	2.3k 2.1×	768 0.8×	541 0.6×	143	7.5k
Bernard Sordat	2.3k 0.9×	1.7k 0.7×	474 0.4×	1.6k 1.6×	426 0.5×	111	5.7k
Christoph Huber	3.3k 1.3×	3.5k 1.5×	791 0.7×	5.0k 5.0×	904 1.0×	155	8.6k

Countries citing papers authored by Albert Deisseroth

Since Specialization

Citations

This map shows the geographic impact of Albert Deisseroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Deisseroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Deisseroth more than expected).

Fields of papers citing papers by Albert Deisseroth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Deisseroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Deisseroth. The network helps show where Albert Deisseroth may publish in the future.

Co-authorship network of co-authors of Albert Deisseroth

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Deisseroth. A scholar is included among the top collaborators of Albert Deisseroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Deisseroth. Albert Deisseroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Przepiorka, Donna, Lola Luo, Sriram Subramaniam, et al.. (2019). FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. The Oncologist. 25(2). e328–e334. 91 indexed citations

Norsworthy, Kelly J., Lola Luo, Vicky Hsu, et al.. (2019). FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation. Clinical Cancer Research. 25(11). 3205–3209. 102 indexed citations

Jen, Emily Y., Aaron J. Schetter, Donna Przepiorka, et al.. (2018). FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease. Clinical Cancer Research. 25(2). 473–477. 98 indexed citations

Przepiorka, Donna, Chia‐Wen Ko, Albert Deisseroth, et al.. (2015). FDA Approval: Blinatumomab. Clinical Cancer Research. 21(18). 4035–4039. 261 indexed citations

Thoman, Marilyn L., et al.. (2009). Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged. Cancer Immunology Immunotherapy. 58(12). 1949–1957. 19 indexed citations

Liu, Ying, et al.. (2007). Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells. Human Pathology. 38(7). 1047–1056. 20 indexed citations

Tang, Yucheng, Hakan Akbulut, Xiangming Fang, et al.. (2006). Vector Prime/Protein Boost Vaccine That Overcomes Defects Acquired during Aging and Cancer. The Journal of Immunology. 177(8). 5697–5707. 12 indexed citations

Zhang, Lixin, Yucheng Tang, Hakan Akbulut, et al.. (2003). An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells. Proceedings of the National Academy of Sciences. 100(25). 15101–15106. 56 indexed citations

Zhang, Lixin, Hakan Akbulut, Yucheng Tang, et al.. (2002). Adenoviral Vectors with E1A Regulated by Tumor-Specific Promoters Are Selectively Cytolytic for Breast Cancer and Melanoma. Molecular Therapy. 6(3). 386–393. 37 indexed citations

10.

Hortobagyi, Gabriel N., Aman U. Buzdar, Richard L. Theriault, et al.. (2000). Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma. JNCI Journal of the National Cancer Institute. 92(3). 225–233. 126 indexed citations

11.

Guo, Xiangyang, et al.. (1999). Presence of P210bcrabl Is Associated with Decreased Expression of a Beta Chemokine C10 Gene in a P210bcrabl-Positive Myeloid Leukemia Cell Line. Molecular Medicine. 5(1). 55–61. 1 indexed citations

12.

Bachier, Carlos, Richard E. Giles, F. García‐Sánchez, et al.. (1999). Hematopoietic Retroviral Gene Marking in Patients with Follicular Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 32(3-4). 279–288. 17 indexed citations

13.

Fu, Siqing & Albert Deisseroth. (1997). Use of the Cosmid Adenoviral Vector Cloning System for the In Vitro Construction of Recombinant Adenoviral Vectors. Human Gene Therapy. 8(11). 1321–1330. 28 indexed citations

14.

Hester, Jeane P., et al.. (1995). Principles of Bone Marrow Processing and Progenitor Cell/Mononuclear Cell Concentrate Collection in a Continuous Flow Blood Cell Separation System. Journal of Hematotherapy. 4(4). 299–306. 3 indexed citations

15.

Owen‐Schaub, Laurie B., Wei Zhang, James C. Cusack, et al.. (1995). Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression. Molecular and Cellular Biology. 15(6). 3032–3040. 615 indexed citations breakdown →

16.

Giles, Richard E., Elie G. Hanania, Siqing Fu, & Albert Deisseroth. (1995). Genetic Therapy Using Bone Marrow Transplantation. Cancer treatment and research. 76. 271–280. 1 indexed citations

17.

Deisseroth, Albert, et al.. (1994). Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology : current aspects and future directions. KARGER eBooks. 1 indexed citations

18.

Kantarjian, Hagop M., C. Frederick LeMaistre, Jorge A. Spinolo, et al.. (1991). Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemia. Cancer. 67(12). 2959–2965. 28 indexed citations

19.

Claxton, David F., Soon‐Pal Suh, Debra Ellerson, et al.. (1991). Molecular Analysis of Retroviral Transduction in Chronic Myelogenous Leukemia. Human Gene Therapy. 2(4). 317–321. 8 indexed citations

20.

Seong, David, Simon H. Sims, Elizabeth Johnson, et al.. (1991). Activation of class I HLA expression by TNF‐alpha and gamma‐interferon is mediated through protein kinase C‐dependent pathway in CML cell lines. British Journal of Haematology. 78(3). 359–367. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact